PASG
Passage Bio Inc
NASDAQ: PASG · HEALTHCARE · BIOTECHNOLOGY
$5.11
-4.49% today
Updated 2026-04-30
Market cap
$18.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.35
Dividend yield
—
52W range
$5 – $20
Volume
0.1M
Passage Bio Inc (PASG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-113.80%
ROA
-32.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-12.77M | — | — | — |
| 2019 | $0.00 | $-45.63M | — | — | — |
| 2020 | $0.00 | $-112.23M | — | — | — |
| 2021 | $0.00 | $-185.39M | — | — | — |
| 2022 | $0.00 | $-136.13M | — | — | — |
| 2023 | $0.00 | $-102.06M | — | — | — |
| 2024 | $0.00 | $-64.77M | — | — | — |
| 2025 | $0.00 | $-45.52M | — | — | — |